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Abstract
Background: The progress and completion of various plant genome sequencing projects has
paved the way for diverse functional genomic studies that involve cloning, modification and
subsequent expression of target genes. This requires flexible and efficient procedures for
generating binary vectors containing: gene fusions, variants from site-directed mutagenesis, addition
of protein tags together with domain swaps and deletions. Furthermore, efficient cloning
procedures, ideally high throughput, are essential for pyramiding of multiple gene constructs.
Results: Here, we present a simple, flexible and efficient PCR-fusion/Gateway cloning procedure
for construction of binary vectors for a range of gene fusions or variants with single or multiple
nucleotide substitutions, short sequence insertions, domain deletions and swaps. Results from
selected applications of the procedure which include ORF fusion, introduction of Cys>Ser
mutations, insertion of StrepII tag sequence and domain swaps for Arabidopsis secondary cell wall
AtCesA genes are demonstrated.
Conclusion: The PCR-fusion/Gateway cloning procedure described provides an elegant, simple
and efficient solution for a wide range of diverse and complicated cloning tasks. Through
streamlined cloning of sets of gene fusions and modification variants into binary vectors for
systematic functional studies of gene families, our method allows for efficient utilization of the
growing sequence and expression data.
Background
The rapid increase in the quantity of publicly available
genome sequence information and expression data for
various plant species provides an excellent resource for
functional genomic studies. Such studies require a variety
of cloning, modification and expression experiments [1].
Utilisation of sequences of known orthologous and/or
paralogous members of gene families combined with
expression data and biochemical analysis respresents a
powerful resource. However, efficient utilisation of this
resource requires a flexible and efficient cloning proce-
dure. This procedure must be suited to gene and promoter
cloning, site-directed mutagenesis, domain deletion and
swapping, protein tagging and reporter gene fusion and
must enable efficient introduction of desired DNA modi-
fication(s) and assembly of DNA fragments regardless of
sequence. The recombinant DNA fragment must then be
subsequently (ideally directly) cloned into Agrobacterium
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binary vectors widely used for plant transformation.
Binary vectors used for Agrobacterium  mediated plant
transformation are large, vary in structure, origin of repli-
cations and tend to be cumbersome for high throughput
cloning using classical techniques. A range of improve-
ments of commonly employed procedures and cloning
methods have been reported. These include expanding
efficiency of classical cloning protocols which make use of
restriction enzyme and ligase reactions by the use of
improved binary vectors and rare cutters [2], employing
site-specific recombinational DNA cloning systems [3]
and application of seamless DNA fusion approaches [4].
Recombinational cloning which utilizes site-specific DNA
recombination offers efficient single step transfer of DNA
segments between vectors. Three recombination systems
are available that allow for efficient DNA cloning: Gate-
way [5,6], Univector [7] and Creator [8]. The Gateway
cloning system has become increasingly popular for con-
struction of binary vectors as several sets of Gateway com-
patible binary vectors have become available [9-13].
These can be used for a wide range of studies including
over- and inducible- gene expression, protein tagging,
reporter gene fusions and gene silencing. Large numbers
of entry clones generated from different plant species as
well as publicly available collections [1,14] have widened
the use of Gateway. More recently, Multisite Gateway
recombination systems have allowed simultaneous
assembly and cloning of two or three DNA fragments into
destination vectors [15,16]. The Gateway cloning proce-
dure utilizes BP and LR clonase reactions (for detailed
description of the Gateway cloning system and nomencla-
ture see [6]). The BP clonase reaction induces recombina-
tion between attB sites which flank the DNA fragment of
interest, and attP sites that flank a CmR-ccdB expression
cassette in a donor vector. Insertion of a DNA fragment
into a donor vector using the BP clonase generates an
entry clone where the inserted DNA is flanked by attL
sites. A subsequent cloning LR step involves recombina-
tion between attL sites on the entry clone and attR sites
which flank a CmR-ccdB cassette in a destination vector.
As a result, a DNA fragment from an entry clone can be
transferred to a destination vector (e.g. binary plant trans-
formation vector) to produce an expression clone. In
expression clones constructed in this manner the inserted
DNA fragment is flanked by 25 bp attB sites. This is one
drawback of Gateway cloning, particularly when applied
to in frame gene fusion or tagging. A recent report by
Dubin and co-workers [17] combines Gateway and classi-
cal cloning to eliminate insertion of attB sequence from
the DNA fusion site, but still requires two different steps.
A further drawback of Gateway is that there is no stream-
lined application for performing of site-directed mutagen-
esis, domain deletion or swapping.
Seamless DNA cloning, where two or more DNA frag-
ments are fused with no unwanted nucleotide sequence at
junction sites [4] is an alternative to recombinational
cloning when precise assembly of the DNA fragments is
required. Seamless cloning procedures also offer flexibil-
ity for introduction of various modifications in DNA frag-
ments [4]. Overlapping PCR involves PCR amplification
of selected DNA regions with complementary primers
generating DNA fragments with overlapping ends [18].
Amplified DNA fragments are linked through annealing
of their overlapping ends followed by PCR amplification
of the entire assembled DNA fragment. The procedure
allows for the introduction of a range of modifications at
any point in the target DNA [18,19] in combination with
joining of multiple DNA fragments [20]. Proof reading
thermostable DNA polymerases have reduced the risk of
errors introduced by PCR to acceptable levels so have
expanded the application of overlap PCR for construction
of long DNA molecules [20]. One drawback of the
method is the low efficiency of direct cloning of assem-
bled DNA fragments into large binary vectors using classi-
cal restriction/ligation cloning so the recombinant DNA
fragment is generally first cloned into a small universal
plasmid vector and subsequently re-cloned it into a binary
vector. This procedure is particularly cumbersome if trans-
fer of the recombinant DNA fragment to binary vectors
with different selectable markers is required. The recent
In-Fusion™ cloning system offers another attractive possi-
bility for seamless cloning of a PCR fragment into linear-
ized vector, as well as simultaneous assembly of two PCR
fragments prior to cloning [21]. The main requirement for
the procedure application is the joined DNA fragments to
contain 15 bp homologous arms. However, the efficiency
of In-Fusion™ cloning for construction of binary vectors
and seamless assembly and cloning of multiple PCR frag-
ments remains to be evaluated.
Arabidopsis secondary cell wall biosynthesis requires
three closely related cellulose synthases AtCesA4, AtCesA7
and AtCesA8 all of which are necessary for assembly of a
functional cellulose synthase complex. Questions remain
as to which amino acid residues and protein domains are
involved in CESA interactions, subcellular trafficking and
function of the complex [22,23]. The CESA proteins offer
the possibility of the kind of genomic study described
above. AtCesA cDNAs are relatively large in size (> 3 kb)
and are cumbersome for introducing DNA modifications
during cloning, however we have constructed a range of
CesA gene variants with nucleotide substitutions, gene
fusions, domain deletions and swaps using a newly devel-
oped PCR-fusion/Gateway cloning procedure. It com-
bines the seamless DNA fusion feature of the overlap PCR
approach with the high efficiency for cloning of PCR frag-
ments of the Getaway cloning system. Using these vari-Plant Methods 2009, 5:14 http://www.plantmethods.com/content/5/1/14
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ants, we demonstrate that this method provides for
versatile and efficient introduction of various DNA modi-
fications followed by streamlined cloning of the modified
DNA fragments directly into binary vectors.
Methods
Reagents and enzymes
PCR-fusion was carried out using Phusion DNA polymer-
ase (Finnzymes; Finland) and a standard thermal cycler.
Gateway recombination reactions were performed with
BP Clonase II and LR Clonase II enzyme mixes (Invitro-
gen). Competent E. coli DH5α cells, were prepared
according to [24]. Plasmid DNA and PCR fragments were
purified using QIAprep® Spin Miniprep Kit and QIAquick®
Gel Extraction and PCR purification kits (Qiagen, Ger-
many). Gateway donor vector pDONR/Zeo was pur-
chased from Invitrogen. The examples described utilize
entry clones pZ1, pZ3 and pZ5 which carry AtCesA8,
AtCesA4 and AtCesA7 cDNAs in pDONR/Zeo [23], respec-
tively. The destination vector p3KC was derived from
pCB2300 following the insertion of [prom AtCesA7/(fra-
meA: ccd, CmR)/NOS] cassette that includes a 1.7 kbp
promoter sequence from AtCesA7 gene fused with frame A
(attR1/ccdB-CmR/attR2) cassette (Invitrogen) and NOS
terminator region, [23].
PCR-fusion: PCR amplification and overlap extension
DNA template(s) and PCR primers are provided in figure
legends. PCR-fusion involves two or three parallel PCR
amplifications from plasmid template(s). PCR fusion of
the amplified fragments through a single overlap exten-
sion was carried out on gel purified PCR fragments from
these parallel reactions. Cycling parameters were identical
for all PCR amplifications in this manuscript using reac-
tion mix and conditions according to Phusion DNA
polymerase guidelines [25]. Annealing temperatures from
plasmid templates were 55°C.
For fusion of two PCR fragments we used 30 μl overlap
extension reactions which contained: 16 μl mixture of the
two PCR fragments (normally 8 μl for each one; approx.
200-800 ng, DNA), 6 μl of 5× Phusion HF Buffer, 3 μl of
2 mM dNTP mix, 0.3 μl of Phusion™ DNA Polymerase (2
U/μl). No primers were added to the overlap extension
mixture. When three DNA fragments were fused, an 18 μl
mixture of the PCR fragments (normally 6 μl for each one)
was used. Generally we used equal volumes of purified
PCR fragments without checking exact DNA concentra-
tions. If the molar ratios of the amplified PCR fragments
appeared to differ substantially (e.g. by more than 5-7
fold, following estimation of DNA band intensities after
agarose electrophoresis), volumes from purified PCR frag-
ments were adjusted accordingly. The reaction mix was
incubated at 98°C for 30 sec., 60°C for 1 min and 72°C
for 7 min. DNA obtained after the overlap extension reac-
tion was purified using a PCR purification kit.
Gateway cloning into Destination vector
Fused PCR fragments were recombined into a Destination
vector using Gateway LR Clonase II enzyme mix kit. LR
reaction mixture of 10 μl contained: 4-7 μl (approx. 50-
300 ng) of DNAs purified following overlap extension, 1
μl (approx. 150 ng) of destination vector and 2 μl of Gate-
way LR Clonase II enzyme mix. Following 2-4 hours incu-
bation at 25°C half of the reaction was removed,
incubated with 1 μl Proteinase K solution for 10 min at
37°C and used for transformation of E. coli cells which
were transformed as described in [24]. The remaining half
of the LR reaction was incubated overnight at 25°C and
subsequently used in E. coli transformations if the first
transformation failed. In the vast majority of cases, the
first E. coli transformation resulted in positive clones and
subsequent transformations with the remaining half of
the LR reaction were not required. If improved efficiency
is required commercially available competent cells could
be used. In the vast majority of cases, one or two of the
obtained colonies were PCR checked prior to identifica-
tion of a positive expression clone. The inserted DNA frag-
ment obtained from each cloning experiment was full
length sequenced using primers matching the vector
regions flanking the inserted DNA fragment and gene spe-
cific primers. DNA sequencing was carried out at the
sequencing facility of University of Manchester.
Results and Discussion
PCR-fusion/Gateway cloning procedure
Gene fusion
The PCR-fusion/Gateway cloning procedure combines the
advantages of overlap extension mediated seamless DNA
fusion with the high cloning efficiency of the Gateway sys-
tem. A PCR-fusion step involves the assembly of two or
more PCR amplified DNA fragments into a fusion frag-
ment flanked by attL1/attL2 sites. The assembled DNA
fragment is subsequently cloned directly into a Gateway
destination vector using an LR Clonase recombination
reaction. This procedure offers exceptional flexibility for
performing various gene fusion and modification applica-
tions which requires the generation of considerably fewer
Gateway donor vectors than would otherwise be required.
An essential requirement for the PCR-fusion/Gateway
procedure is that DNA fragment(s) to be brought together
in a DNA fusion reaction must be present in a Gateway
donor vector (ca. Gateway entry clones; Fig. 1). In this
manuscript, entry clones were made by PCR mediated
addition of attB1/attB2 sites to the DNA fragment of inter-
est which was cloned into pDONR221 or pDONR/Zeo
vectors using BP Clonase reactions. PCR-fusion was then
carried out according to [18], except that the standard PCR
amplification step for generation of DNA fragments with
overlapping ends was followed by a single extension reac-
tion for fusion of these fragments. In most of the experi-
ments we used 30 bp complementary PCR primers SF and
SR (Fig. 1a) that matched the ends of the two DNA frag-Plant Methods 2009, 5:14 http://www.plantmethods.com/content/5/1/14
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PCR-fusion/Gateway procedure: 'gene fusion' protocol Figure 1
PCR-fusion/Gateway procedure: 'gene fusion' protocol. (A) Schematic of gene fusion protocol. PCR amplification from 
entry clones (primer pairs F × SR and SF × R) of fragments with short overlapping ends; joining of the PCR fragments by single 
overlap extension; direct LR clonase II mediated cloning of the assembled DNA fragment into a binary destination vector and 
generation of binary expression vector (expression clone). The recombination of attL1 and L2 sites with attR1 and R2 sites to 
give attB sites flanking the fused DNA fragments during the Gateway cloning are designated. Cassette enables efficient selection 
of entry and expression clones and contains ccdB and chloramphenicol resistance (CmR) genes (indicated with ccd/CmR). (B) 
Generation of AtCesA7 (aa: 1-1007)/AtCesA8 (aa: 965-985) gene fusion. Two fragments were amplified from the starting entry 
clones with primers: clone pZ3 (AtCesA7): F(M13for)-gtaaaacgacggccagt × SR- ggagacgaaaggattaattcttacccaaag and clone 
pZ1(AtCesA8): SF-ctttgggtaagaattaatcctttcgtctcc × R(M13rev)-caggaaacagctatgac. Note that primers F and R are universal M13-
forward and M13-reverse primers matching the vector sequence outside the attL1/attL2 region. The sequences of the overlap-
ping ends of the two PCR fragments and gene fusion site are presented. The primer sequences are underline. The AtCesA8 
sequences are in bold type. (C) Sequencing of the DNA fusion site in binary expression vector p3K3C1 which contained a 
AtCesA7 (aa: 1-1007)/AtCesA8 (aa: 965-985) fusion cloned into p3KC binary destination vector. The fusion site and position of 
SF primer are designated on the DNA sequence.
L1 L2 
F R SR SF
L1 L2
entry clone A 
PCR PCR
L1 L2
expression clone (binary vector) 
L1 L2 
entry clone B 
L1
L2 
A
B
SF primer
AtCesA7 (aa 1-1007) / AtCesA8 (aa 965-985) 
ccd/CmR prom term R1 R2
LR clonase
destination binary vector
prom term B1 B2
single overlap 
extension
...TTCTCTTTGCTTTGGGTAAGAATTAATCCTTTCGTCTCC-3’ -SR
       +
SF- 5’-CTTTGGGTAAGAATTAATCCTTTCGTCTCCAAAACCGAT...
      =
...TTCTCTTTGCTTTGGGTAAGAATTAATCCTTTCGTCTCCAAAACCGAT...
   F  S  L  L  W  V  R  I N  P  E  V  S  K  T  D 
AtCesA7 (aa 1-1007) / AtCesA8 (aa 965 -985) 
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ments to be fused. The application of shorter 24-28 base
complementary primers was successful in few cloning
experiments, as well. The 3'- half of the primers matched
the 5'-end of one DNA fragment of interest. The 5'-half of
the primer corresponded to the 3'-end of the DNA frag-
ment to be fused. The other primers used for the PCR
amplifications from the entry clones were universal prim-
ers matching the donor vector sequences outside of the
attL1/attL2 regions. We routinely used M13 Forward and
Reverse universal primers which are located outside of the
attL1/attL2 region in pDONR221 or pDONR/Zeo vectors.
The PCR amplifications from entry clones with specific
and universal primer pairs resulted in PCR fragments
which contained the corresponding attL site on one end
and 30 bp overlapping region at the other. PCR fragments
were gel-purified and used for the DNA extension mix.
Following a single DNA denaturing/annealing/extension
cycle, the two PCR fragments were seamlessly joined to
generate a DNA fusion fragment surrounded by attL1/
attL2  sites. This fragment was directly cloned into the
desired destination vector using an LR Clonase recombi-
nation reaction (Fig. 1A). The described 'gene fusion' pro-
tocol offers a seamless Gateway cloning alternative to the
Multisite Gateway recombination system. In addition,
application of this protocol avoids the dedicated construc-
tion of specific Gateway entry clones required for Multi-
site Gateway [15,16].
Sequence analysis of one such 'gene fusion' experiment
for construction of a chimeric AtCesA7/AtCesA8 gene is
demonstrated (Fig. 1b, c). The C-terminus of all CESA
proteins possesses a stretch of six transmembrane
domains followed by a short cytoplasmic region. To eluci-
date the functional significance of this C-terminus region,
a large part of the AtCesA7 cDNA including the six trans-
membrane region (aa: 1-1007) was seamlessly fused to
the small part of AtCesA8  cDNA corresponding to the
cytosolic C-terminus region (aa: 965-985; Fig. 1b, c).
Domain deletion
The generation and expression of a set of promoter or cod-
ing region deletion variants are an important part of many
functional studies on promoter or protein domain struc-
ture. Precise DNA domain deletion is readily achieved
using a modified PCR-fusion/Gateway procedure similar
to the 'gene fusion' protocol described above. PCR ampli-
fication of the two terminal regions of the entry clone
using PCR primers that match the flanking DNA of the
region to be deleted (Fig. 2) followed by an overlap exten-
sion step produces a DNA fusion fragment in which the
target DNA domain is seamlessly deleted. The protocol is
likely to be useful for deletions of putative transcription
factor binding sites from promoter regions or precise dele-
tions of selected parts from coding regions. Using this
method we have generated a set of expression clones car-
rying  Arabidopsis  CESA proteins with specific domains
removed for functional analysis (data not shown).
Domain swap
Comparison of orthologous and/or paralogous members
of gene families can provide important insight into the
function of protein domains within gene families such as
enzyme function, protein-protein interaction, protein
complex assembly and sub-cellular localization and traf-
ficking. PCR-fusion/Gateway cloning offers a streamlined
protocol for fast and efficient generation of domain swap
variants (Fig. 3a). The 'domain swap' protocol requires the
domain acceptor gene to be preliminary cloned into an
Entry vector. Donor domains were directly PCR amplified
DNA 'domain deletion' protocol Figure 2
DNA 'domain deletion' protocol. Schematic representa-
tion of a 'domain deletion' using PCR amplification of the two 
terminal regions of the entry clone adjacent to the DNA 
domain to be deleted (designated by 'X'). F and R - represent 
M13 universal primers. SF and SR are complementary PCR 
primers consisting of two fused sections (a and b) that match 
regions flanking the deleted domain. The overlap extension 
results in assembly of the two terminal regions with overlap-
ping ends. The new fragment with deleted DNA domain is 
directly LR clonase cloned into a binary destination vector 
producing binary expression vector, (for details see Fig. 1).
L1 L2
F R
L1 
L2 
L1 L2 
PCR PCR 
overlap 
extension 
X 
LR clonase 
cloning 
prom  B1 B2 
expression clone 
entry clone 
SR SF
a
a
b
b
term
(binary vector)
a b
a bPlant Methods 2009, 5:14 http://www.plantmethods.com/content/5/1/14
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from any available DNA source in which the donor gene
was present. Two pairs of specific complementary PCR
primers (SF1, SR1 and SF2, SR2) that contain the
sequences from donor and acceptor genes that flank the
position of the swapped domain were used (Fig. 3a).
Three PCR fragments were amplified. Two DNA fragments
flanking the domain of interest on the acceptor gene were
amplified with a gene specific and a universal vector
primer from the entry clone. The third PCR fragment con-
taining the donor domain was amplified from any availa-
ble donor gene using specific primers (SF1 × SR2; Fig. 3a).
Overlap extension resulted in seamless fusion of the all
three PCR fragments producing the domain swap variant
of the gene (Fig. 3a) which was subsequently cloned into
an appropriate destination vector using an LR clonase
recombination reaction. The described 'domain swap'
protocol offers clear advantages over classical overlap
extension method in terms of substantially increasing
cloning efficiency and throughput and also over the Mul-
tisite Gateway system in terms of seamless assembly of the
DNA fragments. The protocol was also successfully
applied to seamless joining of more than three DNA frag-
ments (not shown).
By using the 'domain swap' protocol, we generated a set of
cellulose synthase variants in which different domains
were swapped between AtCesA4, AtCesA7 and  AtCesA8
genes. One CesA domain thought to be involved in pro-
tein interaction and complex assembly is a Zn-finger
located close to the N-terminus [26]. A variant of AtCesA4
but with the Zn-finger domain from AtCesA7 was con-
structed using the 'domain swap' protocol (Fig. 3b).
Site-directed mutagenesis
PCR-fusion/Gateway offers efficient introduction of single
nucleotide mutation(s) within a gene (Fig. 4a). For 'site-
directed mutagenesis' an entry clone containing the target
DNA fragment is again used as the template for PCR
fusion. Two specific complementary PCR primers (SF and
SR; Fig. 4a) that carry single nucleotide substitution(s) at
the desired positions but which otherwise match the
region surrounding the nucleotide(s) to be mutated were
designed. We regularly used primers with mutated nucle-
otide(s) flanked on both sides by 10-13 bases. PCR ampli-
fications from the entry clone with pairs of specific and
universal primers produced two PCR fragments contain-
ing the corresponding attL site at one end and overlapping
region with mutated nucleotide(s) at the other. Following
the single overlap extension step, the recombinant DNA
fragment containing the mutated nucleotide(s) was
directly cloned using LR Clonase into a destination vector.
The protocol works well when several closely located
nucleotides have to be mutated (Fig. 4c). Where mutagen-
esis of distantly located nucleotides was required, nucle-
otide substitutions were inserted simultaneously through
PCR amplification and fusion of three or more DNA
regions.
We extensively used the 'site-directed mutagenesis' proto-
col to generate sets of various nucleotide substitution var-
iants of secondary cell wall AtCesA  genes. We made a
series of Cys>Ser mutants in which single or group of Cys
residues were converted to Ser through introducing single
nucleotide mutation(s) in the respective codons.
Sequence analysis of a variant of AtCesA4 in which the last
DNA 'domain swap' protocol Figure 3
DNA 'domain swap' protocol. (A) Schematic of 'domain 
swap' protocol. PCR amplification from the domain acceptor 
entry clone (primer pairs F × SR1 and SF2 × R) of the two 
terminal regions flanking the DNA domain to be replaced. 
PCR amplification (primer pair SF1 × SR2) of the donor 
domain to be inserted. Overlap extension assembly of the 
three PCR fragments with short overlapping ends (for details 
see Fig. 1). Direct LR clonase cloning of the assembled frag-
ment produces the binary expression clone. Note that SF1/
SR1 and SF2/SR2 are complementary primer pairs consisting 
of the edges of both domain acceptor and donor. (B) 
Sequencing of the two DNA fusion sites of expression vector 
p3K235 that contained AtCesA7 (aa: 1-36)/AtCesA4 (aa: 23-
72)/AtCesA7 (aa: 87-1026) domain swap variant in the p3KC 
binary destination vector. Cloning features: domain acceptor 
entry clone - pZ3 (AtCesA7); domain donor - plasmid cDNA 
clone U50150- RIKEN; primer SF1-ctagatggacaattctgcaaagtct-
gtggc; primer SF2- tgcaacactctttacaagcgtctcagagga; The two 
fusion sites at the ends of the domain swapped region are 
designated on the chromatograms.
L1 L2 
F  R  SR1  SF2 
L1  L2 
entry clone: domain acceptor 
PCR  PCR 
overlap 
extension 
LR clonase 
cloning 
SF1  SR2 
PCR 
domain donor 
L1  L2 
L1  L2 
prom  B1 B2 
expression clone 
term
A
B
(binary vector)
AtCesA4
aa 1-36
AtCesA4
aa 87-1026
AtCesA7
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'Site-directed mutagenesis' and 'short sequence insertion' protocols Figure 4
'Site-directed mutagenesis' and 'short sequence insertion' protocols. (A) Schematic 'site-directed mutagenesis' pro-
tocol. PCR amplification of the two terminal regions for creation of overlapping ends with specific primers that harbor mutated 
nucleotide(s). Overlap extension assembly of the PCR fragments then LR clonase cloning of the mutant fragment produces a 
binary expression vector. (B) Schematic 'short sequence insertion' protocol. PCR amplifications of two regions flanking the tag 
insertion position with specific PCR primers tailed with tag sequence. Overlap extension assembly of the PCR fragments with 
overlapped tag sequence ends, direct LR clonase cloning and generation of binary expression vector. (C) Sequence analysis of 
AtCesA4Cys>Ser cDNA mutant in which the codon of Cys1049 residue was converted to Ser (GVDC1049 > GVDS) using the 'site-
directed mutagenesis' protocol. The mutated AtCesA4Cys>Ser cDNA is directly cloned into p3KC binary destination vector. The 
specific forward PCR primer (SF-ggcgtcgactcttaaatgagg), mutated Ser residue and Cys nucleotide from the wt cDNA clone 
replaced in the mutant are designated on the chromatogram. (D) Sequence analysis of AtCesA7 cDNA with in frame inserted 
StrepII tag sequence (aa: WSHPQFEK) in the middle of the spacer region between transmembrane domains 5 and 6. The spe-
cific primers tailed with StrepII sequence used for this were SF- gtctcatcctcaatttgaaaaagatgatgatgactttggag and SF- ttcaaattgaggat-
gagaccatgttgcctttgatgtgacg. Overlap extension assembled StrepII sequence- tailed PCR fragments are directly LR clonase cloned 
into p3KC binary destination vector. The inserted StrepII sequence, place of the insertion in AtCesA7 cDNA and the region of 
overlapping primers are designated on the chromatogram.
A B
L1 L2 
F
R SF
SR
L1 
L2 
L1 L2
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PCR PCR 
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extension 
B1 B2 
- nucleotide substitution
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F
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SR
L1 
L2
L1 L2 
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Cys was converted to Ser (GVDC1049> GVDS) is shown
(Fig. 4c).
Short sequence insertions
Construction of vectors for expression of tagged proteins
generally employs 'classical' cloning with restriction
enzyme and ligase reactions or uses the Gateway system
[12,27] which possesses the drawback of addition of attB
sequence between the tag and coding sequence. Hybrid
Gateway cloning systems [17] combine these procedures
allowing better control over linker sequence but still
involves less efficient restriction and ligation cloning. Fur-
thermore, current tag-cloning procedures are well suited
for fusion of tags to the N- or C- terminus of proteins, but
are not applicable for insertion of tag sequence into spe-
cific locations inside the coding regions. The majority of
the currently employed epitope tags have short nucleotide
sequences [28] and as such are easily incorporated into
primer sequences used in PCR fusion/Gateway (Fig. 4b).
The protocol is similar to those above but with the 3' part
of primers consisting of 12-15 bases that match the region
of DNA sequence flanking the tag insertion position and
a 5' tail with the nucleotide sequence of the tag. PCR with
specific and 'universal' primers resulted in amplifications
of two fragments of target ORF with overlapping ends
containing the fused in frame tag sequence. The assem-
bled ORF with inserted tag sequence was directly cloned
into a Gateway expression vector thus allowing seamless
insertion/fusion of tag sequence in any position of target
ORF. The tag-ORF construct could be inserted directly in
wide range of vectors for expression in bacterial, plant and
other eukaryotic expression systems.
We used the 'short sequence insertion' protocol for inser-
tion of a StrepII tag sequence internally in the AtCesA7
gene coding sequence. The cellulose synthase CESA
plasma membrane proteins possess 8 trans-membrane
domains and the rest of the protein is mainly cytosolic. So
far, functional 6xHis-, FLAG- and StrepII- tagged CESA
proteins were expressed only when the tag sequence was
inserted in the cytosolic N- terminus of the proteins [23].
The functionality of the recombinant tag proteins with an
epitope tag outside the plasma membrane was untested.
This experiment required the tag sequence to be inserted
in short spacer regions between the trans-membrane
domains located outside the plasma membrane. The
sequence analysis of one such AtCesA7 with a StrepII tag
inserted in the short spacer region between transmem-
brane domains 5 and 6 is demonstrated (Fig. 4d).
Procedure efficiency, PCR error, construct pyramiding
The described PCR-fusion/Gateway cloning procedure is
simple to plan and straightforward in application. The
only differences between the different cloning protocols
and experiments are the DNA templates and specific
primers used. Thus the PCR-fusion/Gateway cloning
could be readily scaled up using reaction master mixes
and by performing multiple cloning experiments simulta-
neously. We successfully performed 12 to 15 cloning
experiments in one run, which substantially reduced the
time per cloning experiment. Such multiple cloning
experiments were completed to the point of E. coli trans-
formation within one to two working days. The use of the
same basic PCR-fusion protocol, gel and PCR purification
kits combined with a highly efficient Gateway recombina-
tion cloning step provides reproducible high efficiency of
the entire cloning procedure. In the majority of cases, test-
ing of one or two colonies from each experiment was suf-
ficient to obtain a positive clone. If necessary, affordable
high throughput application of the cloning procedure
could be easily built up through automisation of gel, PCR
reaction and plasmid DNA purification steps using com-
mercially available robotic systems (e.g. 'QIAcube', Qia-
gen, Germany).
One limitation of overlapping PCR has been PCR errors
introduced in the amplified and cloned DNA fragments.
Recently developed proofreading polymerases have
reduced the PCR error rate [20]. We intensively used Phu-
sion DNA polymerase in all PCR-fusion/Gateway cloning
experiments which proved to be accurate, and gave high
yields of long amplicons using shorter extension times
[25]. The PCR-fusion step in our cloning procedure mini-
mizes the possibility of PCR errors as a single PCR ampli-
fication step is used instead of two successive PCR
amplifications employed in the 'classical' overlap exten-
sion PCR protocol [18-20]. Since the PCR-fusion step is
followed by highly efficient Gateway cloning, the amount
of fused DNA fragments generated in a single overlap
extension is sufficient to obtain a good number of positive
clones from each cloning experiment. We performed
more than 50 independent PCR-fusion/Gateway cloning
experiments involving AtCesA  genes (cDNA lenghts
longer than 3 kb). Ten to more than hundred colonies
were obtained from each cloning experiment. Positive
clones were obtained from the all experiments and in
nearly all of them the testing of one or two colonies was
sufficient to identify a positive clone. The inserted DNA
fragment in one positive expression clone (binary vector)
from each cloning experiment was full length sequenced
(> 160 kb total length of cloned and sequenced DNAs)
and we found no sequence errors generated by the PCR-
fusion. This suggests that the described procedure,
together with the use of proofreading DNA polymerases
could be successfully applied for PCR-fusion and cloning
of longer DNA fragments.
Stepwise introduction of modifications into target DNA
and pyramiding of the constructed expression vectors
through transfer of modified DNA fragments between
clones is essential for a wide variety of experiments. Gate-
way cloning allows a modified DNA fragment from anPlant Methods 2009, 5:14 http://www.plantmethods.com/content/5/1/14
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Pyramiding of the modifications/constructs created by the PCR-fusion/Gateway procedure Figure 5
Pyramiding of the modifications/constructs created by the PCR-fusion/Gateway procedure. An example for pyra-
miding of gene modifications engineered by the PCR-fusion/Gateway procedure Showing the construction of an AtCesA7 cDNA 
mutant in which all eight Cys codons are mutated to Ser. Note that the pyramiding scheme described could be applied for all 
described cloning protocols. (A) General Cys residue structure of the Zn-finger domain of the CESA proteins. The two pairs 
of Cys residues which are mutated separately are designated. (B) Schematic of pyramiding of the Cys-residue mutagenesis in 
the Zn-finger domain of AtCesA7. Step 1: two AtCesA7Cys>Ser cDNA mutants are constructed in parallel, starting from wt AtCesA7 
cDNA using the 'site-directed mutagenesis' protocol (Fig. 4a). In mutant expression clone 1 the codons of first pair of Cys are 
converted to Ser and in clone 2 the last pair. The mutated cDNA from expression clones 1 and 2 are generated using BP clon-
ase and Gateway donor vector (pDONR/Zeo) to obtain mutant entry clones 1 and 2. Terminal regions from each of the 
mutated entry clones are PCR amplified with specific primers containing mutated codons of the remaining internal Cys resi-
dues of the Zn-finger. Overlap extension and cloning of the assembled DNA fragment into p3KC binary destination vector 
resulted in expression clone 3 in which all eight Cys codons are mutated to Ser. (C) Sequence analysis of the region of the Zn-
finger domain mutant in expression clone 3. The converted Cys>Ser residues are marked with (*) and replaced nucleotides are 
shown in brackets.
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expression clone to be back-cloned into an Entry vector
using BP Clonase [6] and as such allows flexibility for pyr-
amiding introduced modifications in the starting DNA
fragment. By re-cloning modified DNA from an expres-
sion clone to generate a modified entry clone followed by
a second forward modification we generated successive
site-directed mutagenesis of the Cys residues from the Zn-
finger domain of the AtCesA7 gene using the PCR-fusion/
Gateway cloning procedure (Fig 5). The amino-terminal
of all CESA cellulose synthases possess 8 (4 × 2) cysteine
residues that form a RING-type zinc finger domain (Fig.
5a) [22]. To evaluate the functional significance of the
cysteines at different positions in the domain, we gener-
ated three different AtCesA7Cys>Ser mutants. In the first
round, two Cys>Ser clones were generated independently
using the 'site-directed mutagenesis' protocol. In clone 1,
the first two Zn-finger cysteines were converted to Ser. In
clone 2 the last pair of Zn-finger cysteines were mutated to
Ser (Fig. 5b). These two Cys>Ser clones were back-cloned
into the pDONR/Zeo vector using a BP clonase recombi-
nation reaction producing entry clones 1 and 2 (Fig. 5b).
The two mutated entry clones were subsequently used in
a second round of 'site-directed mutagenesis' cloning,
which resulted in an expression clone with all eight Cys
codons converted to Ser (Fig. 5c). The pyramiding of con-
structs could involve any of the cloning options described
above for PCR-fusion/Gateway.
Procedure requirements
The only prerequisites for application of the PCR-fusion/
Gateway cloning procedure are the availability of entry
clones containing manipulated DNA fragments and suita-
ble destination binary vectors for cloning of the assem-
bled DNA fragment. The easy de novo construction of entry
clones and destination vectors [6], as well as publicly-
available large entry clone collections [14] and sets of
diverse destination vectors [10,12,13] provide a excellent
background for the application of the described proce-
dure.
Conclusion
The PCR-fusion/Gateway cloning procedure described
combines seamless DNA fusion cloning with the power of
the Gateway system. The procedure offers a simple, fast
and efficient method of performing gene fusions and wide
range of gene modifications including site-directed muta-
genesis, short sequence insertions, domain deletion and
swapping, combined with direct cloning into destination
binary vectors. The procedure can be applied to various
scales including high throughput applications and possi-
ble automation of the main labour intensive steps. The
streamlined cloning of the modified DNA fragments into
new entry clones allows for flexible utilisation of binary
vectors with different selectable markers that allows for
pyramiding of different DNA modification.
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